Navigation Links
PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
Date:10/19/2013

SOUTH PLAINFIELD, N.J., Oct. 18, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it will hold its first R&D Day on Friday, October 25, 2013 from 8:30 a.m. to 12:00 p.m. ET at the Four Seasons Hotel in New York City. Members of PTC's senior management and research teams will provide a corporate update and in-depth reviews of the company's scientific platforms and R&D programs.

(Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

A live webcast of the event will be available on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com. The presentation will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.       
PTC is biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and form the basis for collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com  

Forward Looking State
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 This report analyzes ... in US$ Million by the following Product Segments: Sphygmomanometers (Aneroid ... Blood Pressure Transducers. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts are ...
(Date:4/20/2015)... FRANCISCO , April 20, 2015  SillaJen, ... the development of oncolytic immunotherapy products for cancer, ... research at the Annual Meeting of the American ... of a murine adapted version of its lead ... Pexa-Vec is an oncolytic immunotherapy designed to ...
(Date:4/20/2015)... MENLO PARK, Calif. , April 20, 2015 ... device company, announced today the closing of an $18.5 ... and Aisling Capital.  Existing investors Aperture Venture Partners, ... in the round.  Spirox, which is developing a ... Ear, Nose and Throat (ENT) physicians and plastic ...
Breaking Medicine Technology:World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Spirox, Inc. Announces Closing of $18.5MM Series B Financing 2Spirox, Inc. Announces Closing of $18.5MM Series B Financing 3
... Sept. 26, 2011 Luminex Corporation (NASDAQ: ... xMAP Europe 2011, its annual European multiplexing technology symposium, ... The event will feature scientific sessions, workshops, discussion groups, ... around the world who are performing groundbreaking work in ...
... Sept. 26, 2011 Safely storing prescription medications ... other prescription holders. Now, an innovative new device ... dangerous medications—in a small, convenient and more portable ... Developed by CAP-N-LOCK, LLC., The ...
Cached Medicine Technology:Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 2Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 3Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 4New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications 2
(Date:4/20/2015)... April 20, 2015 Early registration is ... and secure your space at the start line. Returning ... Olympic-distance race is limited to 500 participants (actually there’s only ... secured his spot). , Now thru April 30, the entry ... team members; after May 1st, the fee goes up to ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... "It's so hard to put into words ... I really thought I would just be paying for ... I've discovered is this need that other baby loss ... other and walk through this journey together," says Ramsey ... more from these families than I could ever hope ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Tympani ... that it grew its cloud services business 175% ... cloud computing services in addition to its traditional ... together with representatives from Tympani’s cloud partners Faction ... in enterprise-class cloud computing at a Cloud Symposium ...
(Date:4/20/2015)... 2015 The 2015 Market Research ... a professional and in-depth study on the current ... with a focus on the Chinese situation. ... besylate market research are Pfizer, Novartis, Daiichi Sankyo, ... Par Pharma, Cadila Pharmaceuticals, Kangya Pharmaceuticals, Rui Ming ...
Breaking Medicine News(10 mins):Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 2Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 3Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3
... April 1 Avantis Medical Systems, Inc., ... devices, today announced that Matthew Jenusaitis of ConcepTx Medical, ... are pleased to invite someone of Mr. Jenusaitis, experience ... We look forward to working with him and expect ...
... Self-administered Alternative to Injections for Treatment of Vitamin ... Pharmaceuticals, the proprietary products division of a wholly ... PRX ), today announced it has ... Nasal Spray from QOL Medical LLC. ...
... Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or,the "Company"), reported financial ... Year 2008 Highlights, -- Total revenue for ... million, -- Gross margin ... provided by operating activities was $1.95 million, , ...
... PolyScript(R) Labels Enable Fast and Cost-Effective CustomizationSOUTHFIELD, Mich., April ... manufactured specifically to provide equipment with safety warnings or ... to help engineering industries meet the exacting demands made ... (R) and PolyScript ...
... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... that David Gelfand, Ph.D., chief scientific officer, will ... of Science, Technology and Innovation,s (MOSTI) biotechnology conference ... be held April 2, 2009, at the Putrajaya ...
... Quantum Group, Inc. (NYSE Amex: QGP ) ( ... Continental Stock Transfer and Trust Company to act as Transfer ... & CEO, commented, "Continental Stock Transfer has been in business ... reputation as a comprehensive and customer-centric company that can facilitate ...
Cached Medicine News:Health News:Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors 2Health News:Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 2Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 4Health News:China Shenghuo Reports Year 2008 Financial Results 2Health News:China Shenghuo Reports Year 2008 Financial Results 3Health News:China Shenghuo Reports Year 2008 Financial Results 4Health News:China Shenghuo Reports Year 2008 Financial Results 5Health News:China Shenghuo Reports Year 2008 Financial Results 6Health News:China Shenghuo Reports Year 2008 Financial Results 7Health News:China Shenghuo Reports Year 2008 Financial Results 8Health News:China Shenghuo Reports Year 2008 Financial Results 9Health News:Schreiner ProTech Introduces Intelligent Marking Solutions Achieving Process and Cost Optimizations 2Health News:WaferGen's Chief Scientific Officer to Deliver Executive Talk at Malaysian Ministry of Science, Technology and Innovation's PCR Conference 2Health News:WaferGen's Chief Scientific Officer to Deliver Executive Talk at Malaysian Ministry of Science, Technology and Innovation's PCR Conference 3Health News:The Quantum Group Announces Transition to Continental Stock Transfer 2Health News:The Quantum Group Announces Transition to Continental Stock Transfer 3
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Medicine Products: